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Pitt–Hopkins syndrome is a rare genetic disease characterised by severe 
intellectual disability, distinctive dysmorphic features, epilepsy and distinctive breathing 
abnormalities during wakefulness. Here we describe the case of a 22-year-old woman 
with Pitt–Hopkins syndrome who presented with intractable generalised tonic seizures 
from the age of 11 years, which increased in frequency with age and the onset of 
menstruation despite the use of some anticonvulsant drugs. From the age of 16 years, 
polysomnography and video-EEG detected frequent epileptic apnoea during sleep. 
Although the frequency of generalised tonic seizure clusters was reduced using 
phenobarbital and potassium bromide, epileptic apnoea persisted. Furthermore, the 
frequent epileptic apnoea observed in our patient was regarded as a factor involved in 
the aspiration and deterioration of respiratory function. This study shows that patients 
with Pitt–Hopkins syndrome require close monitoring of epileptic apnoea. Moreover, 
long-term EEG and respiratory monitoring are necessary to distinguish epileptic apnoea 






Patients with Pitt–Hopkins syndrome (PTHS) present with characteristic non-
epileptic breathing abnormalities during wakefulness. The most common breathing 
abnormality is paroxysm of hyperventilation, followed by cyanotic breath-holding 
spells while awake. Apnoea and hyperventilation may occur independently from each 
other. In previous studies, nearly half of the patients with PTHS presented with these 
respiratory disturbances (Peippo et al., 2006; Whalen et al., 2012). However, there have 
been few reports regarding breathing abnormalities during sleep (Giurgea et al., 2008; 
de Winter et al., 2016; Motojima et al., 2018). Moreover, almost half of the patients 
with PTHS develop epilepsy, although this can be appropriately controlled using 
antiepileptic drugs (Zollino et al., 2019). Here we describe a case of PTHS with 
frequent epileptic apnoea during sleep and intractable generalised tonic seizures. Our 
experience indicates that EEG monitoring and polysomnography (PSG) are useful for 
detecting and managing epileptic apnoea during sleep and intractable seizures in 




2. Case study 
A 22-year-old Japanese woman presented to our hospital for the assessment of 
epilepsy potentially related to PTHS. She had been born after a full-term pregnancy and 
had no history of problems during the perinatal or neonatal period. She exhibited 
developmental delay and muscular hypotonia throughout her infancy and childhood. 
She developed slowly and required guidance while learning to walk. She was able to 
speak a few words by the age of 6 years. At the age of 11 years, she began to experience 
frequent generalised tonic seizures. The frequency of seizures increased with age and 
was aggravated at the onset of menstruation. Motor and mental abilities deteriorated 
with increasing frequency of seizures. At approximately 16 years of age, she exhibited 
frequent apnoea during sleep, as detected by PSG, when deterioration of generalised 
tonic seizure clusters was observed for more than half of a 1-month period (Figure 1). 
She was referred to our hospital at the age of 18 years for seizure control and 
examination of underlying disease. Cerebral MRI revealed mild atrophy of the bilateral 
anterior, parietal and left temporal lobes, indicating decreased white matter volume. At 
approximately 20 years of age, she required frequent hospitalisation owing to the 
occurrence of seizure clusters and onset of aspiration pneumonia. Interictal EEG at 20 
years of age revealed periodic diffuse slow spikes and waves of 1–2 Hz, which lasted 
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for a few seconds (Figure 2A). These characteristic abnormal waves were observed in 
both awake and sleep states. Furthermore, ictal EEG revealed diffuse 13–15-Hz fast 
waves predominantly in the bilateral central–parietal–occipital region, followed by 
rhythmic α- and β-waves, corresponding to the arrest of thoracic movement (Figure 
2B). Another ictal EEG of apnoea revealed the sudden onset of diffuse rhythmic 12–14 
Hz α- and β-waves, lasting for 5–40 s, accompanied by the arrest of thoracic movement 
(Figure 2C). The patient exhibited breath-holding followed by deep expiration while 
awake, although this was not accompanied by epileptic discharges, as observed on EEG. 
After experiencing involuntary arm movement for a few seconds, the patient also 
presented with generalised tonic seizures with neck flexion. Ictal EEG revealed 
generalised α- and β-waves with a gradual increase in amplitude, preceded by 
generalised spike and shift to slow spike and wave activities (Supplementary Figure 1). 
The frequency of generalised tonic seizure clusters decreased following phenobarbital 
(PB) and potassium bromide (KBr) administration. However, epileptic apnoea during 
sleep followed by video-EEG monitoring was resistant to any antiepileptic drugs. When 
the patient was 21 years old, PTHS was suspected owing to her dysmorphic features, 
upslanting palpebral fissures, deep-set eyes, wide mouth with thick lips, long and 
slender fingers and toes, microcephaly, severe mental retardation, lack of speech, 
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breath-holding, followed by deep expiration while awake and sudden-onset smile. The 
patient became wheelchair-bound and could not sit without support; at 21 years of age. 
Gastrostomy tube feeding was initiated owing to dysphagia and repeated aspiration 
pneumonia. Although generalised tonic seizure clusters were controlled relatively well, 
regular EEG monitoring demonstrated that epileptic apnoea persisted. 
After obtaining written informed consent from all participants, genomic DNA 
extracted from peripheral blood samples from the proband was analysed using multiplex 
targeted sequencing. The amplicon libraries of the target exons from seven genes with 
phenotypes overlapping with Angelman syndrome (UBE3A, SLC9A6, TCF4, MBD5, 
CDKL5, MECP2 and FOXG1) were prepared using the Ion AmpliSeq Custom Panel 
(Thermo Fisher Scientific, Waltham, MA, USA). Data processing was performed as 
described previously (Negishi et al. 2017). In the TCF4 gene (NM_001083962.1), we 
identified a heterozygous single nucleotide substitution (c.1732C>T; p.Arg578Cys), 
which was previously reported as the cause of PTHS (Marangi G et al. 2012). The 
presence of this variant was validated using Sanger sequencing. The institutional review 
board of the Graduate School of Medical Sciences of Nagoya City University approved 




The disease course of this patient highlighted two important clinical issues. 
First, overnight EEG monitoring and PSG revealed frequent epileptic apnoea during 
sleep. Second, the patient developed intractable generalised tonic seizures, which were 
well controlled with PB and KBr. 
Few reports have described breathing abnormalities during sleep in 
patients with PTHS; however, only obstructive sleep apnoea, catathrenia and nocturnal 
irregular breathing have been documented (Giurgea et al., 2008; de Winter et al., 2016; 
Motojima et al., 2018). Furthermore, to our knowledge, there are no descriptions of 
using overnight EEG monitoring or PSG to evaluate sleep disorders in patients with 
PTHS. Presumably, typical characteristic breathing abnormalities of PTHS during 
wakefulness (i.e. hyperventilation followed by breath-holding) do not accompany 
paroxysmal EEG abnormalities (Amiel et al., 2007; Takano et al., 2010; de Winter et 
al., 2016). PTHS is caused by the haploinsufficiency of TCF4, which encodes for the 
basic helix-loop-helix (bHLH) transcription factor (Amiel et al., 2007; Zweier et al., 
2007). TCF4 forms a heterodimer with Achaete-scute homolog 1 (ASCL1), which is 
another bHLH transcription factor and activates the ASCL1-PHOX-RET pathway, 
which is responsible noradrenergic neuron development in the brainstem (de Pontual et 
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al., 2003, Zweier et al., 2007). Therefore, TCF4 gene mutations cause impaired 
neuronal development in the brainstem and breathing abnormalities while awake. 
Moreover, these breathing abnormalities during wakefulness are likely to be a 
congenital brainstem dysfunction, not an epileptic characteristic. Breath-holding 
followed by deep expiration while awake, as observed in this patient, is presumed to be 
a characteristic breathing abnormality in patients with PTHS. Meanwhile, regarding 
nocturnal breathing abnormalities, Maini et al. reported a single case with PTHS 
presenting with a physiologically normal sleep structure confirmed via PSG (Maini et 
al., 2012). Whalen et al. described nocturnal apnoea without preceding 
hyperventilation, which was observed in three patients with PTHS, as a characteristic 
breathing abnormality. In those patients, the possibility of epileptic apnoea cannot be 
denied because EEG and PSG were not performed (Whalen et al., 2012). Whether 
apnoea is accompanied by deep expiration or hyperventilation might be important for 
distinguishing epileptic and non-epileptic breathing abnormalities. Notably, breathing 
abnormalities, particularly apnoea without accompanying hyperventilation, during sleep 
might be an epileptic condition and have different mechanisms from characteristic 
breathing abnormalities during wakefulness. Furthermore, epileptic apnoea observed in 
the present patient must be differentiated from the arrest of thoracic movement 
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secondarily caused by generalised tonic seizures because ictal EEG corresponding to the 
arrest of thoracic movement in Figure 2C and that of the onset of generalised tonic 
seizure in Supplementary Figure 1 were similar. Although no clinical seizure was 
observed upon video monitoring, it was unclear whether apnoea was associated with 
generalised tonic seizures due to the absence of simultaneous recording of 
electromyography with ictal EEG. In summary, in patients with nocturnal breathing 
disturbance, epileptic apnoea should be more closely examined, and overnight EEG 
monitoring with electromyography and recording of thoracic movement should be 
performed to detect and manage epileptic seizures, in addition to PSG, as recommended 
in the most recent international consensus statement for PTHS (Zollino et al., 2019). 
Our patient developed intractable generalised tonic seizures at 11 years of 
age. Generalised tonic seizure clusters were aggravated with the onset of menstruation; 
these seizures were refractory to various antiepileptic drugs during early treatment. The 
patient was frequently admitted to the hospital due to recurring aspiration pneumonia 
associated with generalised tonic seizure clusters. We assumed that this patient had 
recurrent aspiration pneumonia related to dysphagia caused by brainstem dysfunction 
associated with PTHS, resulting in deteriorating respiratory function. However, few 
reports have described the detailed clinical courses of epilepsy in patients with PTHS. 
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According to previous reports, epilepsy in patients with PTHS can be controlled 
relatively well with one or two standard antiepileptic drugs (Whalen et al., 2012; 
Marangi and Zollino, 2015; de Winter et al., 2016), although few patients may develop 
intractable epilepsy, such as infantile spasms and Lennox–Gastaut Syndrome (Peippo et 
al., 2006; de Pontual et al., 2009). However, the most effective AED is unclear owing to 
limited reports (de Winter et al., 2016). Because PB and KBr were effective in reducing 
the frequency of generalised tonic seizure clusters in our patient, they might be useful 
for suppressing seizure clusters in patients with PTHS. 
In conclusion, patients with PTHS can present with frequent epileptic 
apnoea during sleep and intractable generalised tonic seizures. EEG monitoring and 
PSG should therefore be performed for patients with PTHS. Further investigations of 
epilepsy, EEG and PSG findings and detailed examinations of sleep disturbances are 
warranted to determine whether epileptic apnoea and intractable seizures occur more 
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Fig 1. Clinical course of epilepsy: The line graph shows the number of days per month 
that the patient experienced tonic seizure clusters. Abbreviations indicate antiepileptic 
drugs prescribed. 
(*) No specific records were collected during this period. 
Abbreviations: VPA: valproic acid, ZNS: zonisamide, LTG: lamotrigine, CLB: 
clobazam, PHT: phenytoin, NZP: nitrazepam, TPM: topiramate, LEV: levetiracetam, 
PB: phenobarbital, CZP: clonazepam, RFN: rufinamide, KBr: potassium bromide 
Fig 2. Interictal and ictal EEG findings: 
(A) Interictal EEG findings during sleep at 20 years of age revealed diffuse periodic 1–
2-Hz diffuse slow spikes and waves lasting for a few seconds. 
(B) Ictal EEG findings during apnoea at 20 years of age. Diffuse 200–300- V high 
amplitude and diffuse 13–15-Hz fast waves (Black bar) followed by rhythmic α and β 
activities corresponding to the arrest of thoracic movements were observed. 
(C) Ictal EEG findings of consecutive epileptic apnoea. Diffuse rhythmic 12–14-Hz α- 
and β-waves were preceded by arrest of thoracic movement lasting for 30 s. Arrowhead 
indicates the onset and cessation of apnoea. The EEG description for approximately 10 
s in the middle of apnoea was omitted.  
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Supplementary Figure 1: Ictal EEG findings of generalised tonic seizures. These two 
figures are ictal EEG of the same consecutive generalised tonic seizure. Each figure 
indicates the (A) onset and (B) cessation of the seizure. A generalised spike, followed 
by α- and β-waves with a gradual increase in amplitude, was observed at the onset of 
seizure; it shifted to slow spike and wave activities according to the cessation of seizure 
lasting for 25 s. The white arrowhead indicates the onset of involuntary arm movement, 
and the black arrowhead indicates (A) the onset and (B) cessation of the generalised 
tonic seizure with neck flexion. 
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Questions (Test Yourself) 
1) What types of sleep disturbances have been reported in patients with PTHS? 
2) What percentage of patients with PTHS experience epilepsy and what is the optimal 
treatment for epilepsy? 
3) What examinations were useful for distinguishing nocturnal breathing abnormalities 
in this patient? 
 
Answers 
1) Obstructive sleep apnoea, catathrenia and nocturnal irregular breathing have been 
reported as breathing abnormalities during sleep, although these sleep disturbances have 
rarely been evaluated using PSG. The present report describes a patient with nocturnal 
epileptic apnoea detected via overnight EEG monitoring. 
2) Almost half of the patients with PTHS experience epilepsy, although this can be 
controlled relatively well with antiepileptic drugs. Some patients may develop 
intractable epilepsy, such as infantile spasms and Lennox–Gastaut Syndrome. The most 
effective AED is unclear owing to limited number of reports. 
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3) Overnight video-EEG monitoring was useful for detecting and managing epileptic 
apnoea, in combination with polysomnography, as recommended in the most recent 
international consensus statement for PTHS. 



